Trends in the incidence and DALYs of anxiety disorders at the global, regional, and national levels: Estimates from the Global Burden of Disease Study 2019

疾病负担 医学 入射(几何) 焦虑 疾病负担 环境卫生 人口学 流行 人口 精神科 光学 物理 社会学
作者
Peng Xiong,Min Liu,Bo Liu,Brian J. Hall
出处
期刊:Journal of Affective Disorders [Elsevier BV]
卷期号:297: 83-93 被引量:67
标识
DOI:10.1016/j.jad.2021.10.022
摘要

Anxiety disorders are the second leading mental health-related cause of disability-adjusted life-years (DALYs) and years lived with disability (YLDs) worldwide. This study aimed to quantitatively assess the burden of anxiety disorders at the global, regional, and national levels in 1990 and 2019 and the trends over this period. We used data for incidence cases, DALYs, age-standardized incidence rate (ASIR) and age-standardized DALYs rate (ASDR) from Global Burden of Disease Study 2019 (GBD 2019) and calculated the estimated annual percentage changes (EAPCs) to assess the incidence rate and DALYs rate trends for anxiety disorders. The incidence cases of anxiety disorders increased by 47.19%, from 31.13 million in 1990 to 45.82 million in 2019, and DALYs increased by 53.70%, from 18.66 million in 1990 to 28.68 million in 2019. Over the past 29 years, the changes of ASIR and ASDR worldwide were stable (EAPC = 0.011 and -0.001, respectively). Women were more likely to experience anxiety disorders. Participants aged 10–14 had the highest incidence rate, followed by those aged 35–44. Those aged 15–19 and 40–44 had the highest estimated DALYs rate. The ASIR and ASDR were estimated to be the highest in Iran and Portugal, and Portugal and Brazil, respectively. Both of ASIR and ASDR were high in high- sociodemographic index regions in 2019. Further exploration of related risk factors needs to be analyzed in the future studies. Compared with 1990, the absolute increase in incidence cases and DALYs of anxiety disorders in 2019 still remained high. Our findings contribute to the formulation of health policies for controlling and preventing anxiety disorders in different countries and regions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
香蕉觅云应助lvxinda采纳,获得10
刚刚
刚刚
Zzz完成签到,获得积分10
1秒前
HmH完成签到,获得积分10
1秒前
佳佳完成签到,获得积分10
1秒前
情怀应助MoonByMoon采纳,获得10
1秒前
123发布了新的文献求助30
1秒前
1秒前
2秒前
ddddansu完成签到,获得积分10
2秒前
科研通AI5应助美丽秋蝶采纳,获得10
2秒前
沈沈完成签到,获得积分10
3秒前
jing发布了新的文献求助10
3秒前
wxr完成签到 ,获得积分10
3秒前
3秒前
5秒前
一棵完成签到 ,获得积分10
5秒前
qiao完成签到,获得积分10
5秒前
5秒前
汉堡包应助Pendulium采纳,获得10
6秒前
hdbys完成签到,获得积分10
6秒前
6秒前
量子星尘发布了新的文献求助10
7秒前
7秒前
周轩完成签到,获得积分10
8秒前
liusj完成签到,获得积分10
8秒前
ss发布了新的文献求助10
8秒前
Miyo完成签到,获得积分10
9秒前
9秒前
9秒前
高贵的帽子完成签到 ,获得积分10
9秒前
AN完成签到,获得积分10
9秒前
Catalysis123发布了新的文献求助10
10秒前
10秒前
开心的人杰完成签到,获得积分10
11秒前
科目三应助儒雅大象采纳,获得10
12秒前
共享精神应助Feijiahao采纳,获得10
12秒前
JBY发布了新的文献求助10
12秒前
13秒前
顺顺黎黎完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Acute Mountain Sickness 2000
A novel angiographic index for predicting the efficacy of drug-coated balloons in small vessels 500
Textbook of Neonatal Resuscitation ® 500
Thomas Hobbes' Mechanical Conception of Nature 500
The Affinity Designer Manual - Version 2: A Step-by-Step Beginner's Guide 500
Affinity Designer Essentials: A Complete Guide to Vector Art: Your Ultimate Handbook for High-Quality Vector Graphics 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5097673
求助须知:如何正确求助?哪些是违规求助? 4310117
关于积分的说明 13429226
捐赠科研通 4137515
什么是DOI,文献DOI怎么找? 2266700
邀请新用户注册赠送积分活动 1269881
关于科研通互助平台的介绍 1206170